Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Gilead Sciences Inc. (GILD) shares rose 1.87% to $146.12, outperforming peers like Johnson & Johnson and Pfizer on a strong trading day. The stock closed 7.10% below its 52-week high of $157.29. While the broader market rallied with the S&P 500 up 0.43%, Gilead's trading volume remained below its 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Gilead Sciences Inc. (GILD) rallied 1.87% to $146.12 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.43% to 7,674.37 and the Dow Jones Industrial Average rising 0.98% to 53,277.01.
Gilead Sciences Inc. closed 7.10% short of its 52-week high of $157.29, which the company achieved on February 11th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) rose 1.07% to $270.24, Pfizer Inc. (PFE) rose 1.01% to $28.07, and Abbott Laboratories (ABT) rose 2.19% to $116.64.
Trading volume (5.0 M) remained 2.4 million below its 50-day average volume of 7.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 21, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-21-26 1635ET